Raffles Medical Group Ltd
RAFLF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,699 | $1,889 | $2,117 | $2,367 |
| - Cash | $344 | $344 | $253 | $265 |
| + Debt | $88 | $125 | $96 | $198 |
| Enterprise Value | $1,444 | $1,670 | $1,960 | $2,301 |
| Revenue | $752 | $708 | $823 | $724 |
| % Growth | 6.1% | -14% | 13.7% | – |
| Gross Profit | $486 | $316 | $640 | $581 |
| % Margin | 64.7% | 44.6% | 77.8% | 80.2% |
| EBITDA | $136 | $133 | $236 | $161 |
| % Margin | 18.1% | 18.8% | 28.7% | 22.3% |
| Net Income | $62 | $90 | $143 | $84 |
| % Margin | 8.3% | 12.7% | 17.4% | 11.6% |
| EPS Diluted | 0.033 | 0.048 | 0.077 | 0.045 |
| % Growth | -30.7% | -37.3% | 71.3% | – |
| Operating Cash Flow | $86 | $189 | $196 | $160 |
| Capital Expenditures | -$21 | -$21 | -$25 | -$53 |
| Free Cash Flow | $65 | $169 | $171 | $107 |